OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
134356

Sun Rise E&T Corp

Commodity ChemicalsVerified

Sun Rise E&T Corp has a debt-to-equity ratio of 1.54, indicating a capital structure that is significantly leveraged. The company's liquidity position is weak, with a current ratio of 0.49, suggesting that it may struggle to meet short-term obligations without external financing. The negative net cash position, after subtracting total debt, further highlights the company's liquidity constraints. The company's profitability is underperforming, with a return on equity of -17.95% and a return on assets of -6.43%, both significantly below the industry median for Commodity Chemicals. These metrics indicate that the company is not generating returns that meet the cost of capital or the expectations of its equity holders. Sun Rise E&T Corp's revenue is concentrated in Asia and Europe, with no disclosed breakdown of regional contributions. The company's product portfolio includes high-density polyethylene pipes and related accessories, with applications in floating solar power generation, sewage treatment, and marine aquaculture. However, the lack of segment-specific revenue data limits the ability to assess geographic or product concentration risks. The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent fiscal year. The operating income and net income are negative, indicating a lack of profitability. The capital expenditure of -29.71 million TWD suggests that the company is not investing in new capacity or expansion, which may limit its ability to grow in the future. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative operating cash flow and free cash flow suggest that it is not generating sufficient internal cash to fund operations or reduce debt. The dilution risk is low, as the number of shares outstanding has not changed between basic and diluted shares. Recent events include the company's 2023 10-K filing, which disclosed the company's financial performance and risk factors. The company has not issued any recent press releases or earnings transcripts that would indicate significant changes in its business strategy or financial position.

30-day price · 1343-4.40 (-16.9%)
Low$19.55High$26.10Close$21.70As of15 May, 00:00 UTC
Profile
CompanySun Rise E&T Corp
Ticker1343.TWO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Sun Rise E&T Corp is a Taiwan-based company engaged in the research, development, manufacturing, and sales of high-density polyethylene pipes, with products used in floating solar power generation systems, sewage treatment, marine aquaculture, and wind power projects.

Classification. Sun Rise E&T Corp is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92.

Sun Rise E&T Corp has a debt-to-equity ratio of 1.54, indicating a capital structure that is significantly leveraged. The company's liquidity position is weak, with a current ratio of 0.49, suggesting that it may struggle to meet short-term obligations without external financing. The negative net cash position, after subtracting total debt, further highlights the company's liquidity constraints. The company's profitability is underperforming, with a return on equity of -17.95% and a return on assets of -6.43%, both significantly below the industry median for Commodity Chemicals. These metrics indicate that the company is not generating returns that meet the cost of capital or the expectations of its equity holders. Sun Rise E&T Corp's revenue is concentrated in Asia and Europe, with no disclosed breakdown of regional contributions. The company's product portfolio includes high-density polyethylene pipes and related accessories, with applications in floating solar power generation, sewage treatment, and marine aquaculture. However, the lack of segment-specific revenue data limits the ability to assess geographic or product concentration risks. The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent fiscal year. The operating income and net income are negative, indicating a lack of profitability. The capital expenditure of -29.71 million TWD suggests that the company is not investing in new capacity or expansion, which may limit its ability to grow in the future. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative operating cash flow and free cash flow suggest that it is not generating sufficient internal cash to fund operations or reduce debt. The dilution risk is low, as the number of shares outstanding has not changed between basic and diluted shares. Recent events include the company's 2023 10-K filing, which disclosed the company's financial performance and risk factors. The company has not issued any recent press releases or earnings transcripts that would indicate significant changes in its business strategy or financial position.
Key takeaways
  • Sun Rise E&T Corp is operating at a loss, with negative operating and net income.
  • The company's capital structure is highly leveraged, with a debt-to-equity ratio of 1.54.
  • The company's liquidity position is weak, with a current ratio of 0.49.
  • The company is not generating returns on equity or assets that meet industry benchmarks.
  • The company's growth trajectory is uncertain, with no disclosed revenue growth and negative cash flows.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$471.3M
Gross profit$103.3M
Operating income-$111.9M
Net income-$80.0M
R&D
SG&A
D&A
SBC
Operating cash flow-$122.8M
CapEx-$29.7M
Free cash flow-$101.3M
Total assets$1.24B
Total liabilities$798.3M
Total equity$445.8M
Cash & equivalents$23.9M
Long-term debt$687.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$445.8M
Net cash-$663.3M
Current ratio0.5
Debt/Equity1.5
ROA-6.4%
ROE-17.9%
Cash conversion1.5%
CapEx/Revenue-6.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric1343Activity
Op margin-23.7%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-17.0%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin21.9%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-6.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity154.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 04:44 UTC#c300dddd
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 16:51 UTCJob: 1f214c09